《广州医药》
点击关注官方服务号追踪稿件状态

【重要服务提醒】《广州医药》杂志服务号已上线稿件查询功能

各位作者、审稿专家:
本刊官方微信服务号新增稿件状态查询服务,无需反复登录投稿系统,微信即可随时查看审稿进度、修回通知、录用结果,稿件更新实时推送提醒,同步接收期刊征稿、学术资讯。

操作方式

微信搜索关注广州医药杂志服务号 → 点击菜单栏「绑定账号」→ 输入投稿邮箱完成账号关联;请关闭微信消息免打扰,避免遗漏稿件通知。

《广州医药》编辑部

广州医药杂志服务号

张文清

二级教授、博士生导师、医学博士
发育生物学与再生医学团队负责人
细胞生物学教研室主任
先后创建了南方医科大学和华南理工大学发育生物学团队
从事造血发育、疾病模型与药物筛选研究。
通过ENU化学诱变或小分子随机突变等正向遗传学筛选技术发现并鉴定了多个调控斑马鱼髓系造血发育的新基因和小分子,建立了数种人类遗传性血液病的斑马鱼模型。
获各类国家自然科学基金12项,科技部973、863及重点研发课题各1项,广东省自然科学基金团队项目1项。 
以通讯作者在Blood、Leukemia、elife、Development、JBC等SCI期刊发表论文30篇,合作作者发表SCI论文33篇,相关斑马鱼白血病模型专利授权4件。
Second-Level Professor, Doctoral Supervisor, Medical Doctor (MD)
Leader of the Developmental Biology and Regenerative Medicine Research Team  
Director of the Cell Biology Teaching and Research Division  
He has successively established developmental biology research teams at Southern Medical University and South China University of Technology. His research focuses on hematopoietic development, disease modeling, and drug screening. Using forward genetic screening techniques such as ENU chemical mutagenesis and small-molecule random mutagenesis, he has discovered and identified multiple novel genes and small molecules regulating myeloid hematopoietic development in zebrafish. He has also established several zebrafish models for human hereditary blood diseases.  
He has been awarded 12 National Natural Science Foundation projects, 1 project each under the Ministry of Science and Technology's 973 Program, 863 Program, and Key R&D Program, and 1 team project from the Guangdong Natural Science Foundation.  
As a corresponding author, he has published 30 SCI papers in journals such as "Blood", "Leukemia", "eLife", "Development", and "Journal of Biological Chemistry (JBC)". He has also co-authored 33 SCI papers. Additionally, he holds 4 authorized patents related to zebrafish leukemia models.
出版者信息








《广州医药》公众号